Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
Steve Potts is developing medicines for hard-to-treat cancers. Just don’t ask what, exactly, he’s working on. If word gets out, he fears a Chinese company could beat him to market. on.wsj.com/4h2K8Ld
https://on.wsj.com/4h2K8Ld
2026-07-10T03:45:04.072Z